Straumann Holding AG Debt to Equity Ratio 2012-2024 | SAUHY

Current and historical debt to equity ratio values for Straumann Holding AG (SAUHY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Straumann Holding AG debt/equity for the three months ending December 31, 2024 was 0.00.
Straumann Holding AG Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $1.79B $2.32B 0.77
2024-06-30 $1.67B $2.18B 0.76
2023-12-31 $1.65B $2.05B 0.81
2022-12-31 $1.59B $1.94B 0.82
2021-12-31 $1.61B $1.64B 0.98
2021-06-30 $1.59B $1.50B 1.06
2020-12-31 $1.43B $1.29B 1.11
2020-06-30 $1.17B $1.10B 1.06
2019-12-31 $1.03B $1.38B 0.75
2018-12-31 $0.68B $1.23B 0.55
2017-12-31 $0.62B $1.09B 0.57
2017-06-30 $0.54B $0.66B 0.81
2016-12-31 $0.46B $0.64B 0.72
2016-06-30 $0.48B $0.75B 0.64
2015-12-31 $0.46B $0.63B 0.73
2014-12-31 $0.46B $0.81B 0.58
2013-12-31 $0.42B $0.68B 0.62
2013-06-30 $0.38B $0.64B 0.60
2012-12-31 $0.15B $0.67B 0.22
2012-06-30 $0.18B $0.69B 0.26
2011-12-31 $0.16B $0.76B 0.21
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $21.989B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.057B 21.50
Becton Dickinson (BDX) United States $53.114B 13.15
Cardinal Health (CAH) United States $37.506B 19.64
West Pharmaceutical Services (WST) United States $18.932B 37.86
Cooper (COO) United States $14.917B 19.22
Align Technology (ALGN) United States $14.900B 29.58
Henry Schein (HSIC) United States $8.698B 14.92
Merit Medical Systems (MMSI) United States $5.005B 24.20
DENTSPLY SIRONA (XRAY) United States $3.195B 9.54
CONMED (CNMD) United States $1.576B 11.79
STAAR Surgical (STAA) United States $0.951B 0.00
Lifevantage (LFVN) United States $0.173B 17.81
Pro-Dex (PDEX) United States $0.161B 17.65